Liver Transplantation in Patients With Cryptogenic Cirrhosis: Long-Term Follow-up

被引:12
作者
Alamo, J. M. [1 ]
Bernal, C. [1 ]
Barrera, L. [1 ]
Marin, L. M. [1 ]
Suarez, G. [1 ]
Serrano, J. [1 ]
Gomez, M. A. [1 ]
Padillo, F. J. [1 ]
机构
[1] Virgen del Rocio Hosp, Liver Transplant Unit, Seville, Spain
关键词
UNKNOWN VIRUSES; HEPATITIS; INFECTION;
D O I
10.1016/j.transproceed.2011.05.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective. The objective of this study was to evaluate long-term survival, histological diagnoses, and mobility of patients with cryptogenic cirrhosis (CC) treated with orthotopic liver transplantation (OLT). Patients and Methods. We performed a retrospective analysis of 35 patients who underwent transplantation with CC among 800 OLT patients. There were no differences in gender, mean age of 47 years, average MELD (Model for End-stage Liver Disease) of 16, and hepatocellular carcinoma incidence (8%). Results. In 28.6% of patients, the diagnosis of CC was wrong. There was no incidence of an acute rejection episode and a low incidence of complications, although the postoperative mortality rate was 20%, of chronic rejection was 25%, and recurrence of disease was 4%. Cumulative at 3-, 5-, and 10-year survivals were lower than the other OLT. Survival was lower in patients receiving suboptimal grafts. Conclusions. One of 3 patients who underwent transplantation for CC had a specific etiologic diagnosis. The chronic rejection rate and postoperative mortality rate were higher than other etiologies, and survivals at 5, 10, and 15 years were lower than other OLT.
引用
收藏
页码:2230 / 2232
页数:3
相关论文
共 14 条
[1]   Distinct enzyme profiles in patients with cryptogenic cirrhosis reflect heterogeneous causes with different transplantation (OLT):: A long-term documentation before and after OLT [J].
Berg, T ;
Neuhaus, R ;
Klein, R ;
Leder, K ;
Lobeck, H ;
Beckstein, WO ;
Müller, AR ;
Wiedenmann, B ;
Hopf, U ;
Berg, PA ;
Neuhaus, P .
TRANSPLANTATION, 2002, 74 (06) :792-798
[2]   Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease [J].
Caldwell, SH ;
Oelsner, DH ;
Iezzoni, JC ;
Hespenheide, EE ;
Battle, EH ;
Driscoll, CJ .
HEPATOLOGY, 1999, 29 (03) :664-669
[3]   TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis [J].
Charlton, M ;
Adjei, P ;
Poterucha, J ;
Zein, N ;
Moore, B ;
Therneau, T ;
Krom, R ;
Wiesner, R .
HEPATOLOGY, 1998, 28 (03) :839-842
[4]  
Charlton M R, 1997, Liver Transpl Surg, V3, P359, DOI 10.1053/jlts.1997.v3.pm0009346764
[5]   Hepatitis G virus infection in patients transplanted for cryptogenic cirrhosis - red flag or red herring? [J].
Charlton, MR ;
Brandhagen, D ;
Wiesner, RH ;
Gross, JB ;
Detmer, J ;
Collins, M ;
Kolberg, J ;
Krom, RAF ;
Persing, DH .
TRANSPLANTATION, 1998, 65 (01) :73-76
[6]  
GOMEZ R, 1995, TRANSPLANT P, V27, P2299
[7]   CIRRHOSIS OF UNDEFINED PATHOGENESIS - ABSENCE OF EVIDENCE FOR UNKNOWN VIRUSES OR AUTOIMMUNE PROCESSES [J].
GREEVE, M ;
FERRELL, L ;
KIM, M ;
COMBS, C ;
ROBERTS, J ;
ASCHER, N ;
WRIGHT, TL .
HEPATOLOGY, 1993, 17 (04) :593-598
[8]   High prevalence of hepatitis G virus after liver transplantation without apparent influence on long-term graft function [J].
Haagsma, EB ;
Cuypers, HTM ;
Gouw, ASH ;
Sjerps, MC ;
Huizenga, JR ;
Slooff, MJH ;
Jansen, PLM .
JOURNAL OF HEPATOLOGY, 1997, 26 (04) :921-925
[9]   Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases [J].
Maor-Kendler, Y ;
Batts, KP ;
Burgart, LJ ;
Wiesner, RH ;
Krom, RA ;
Rosen, CB ;
Charlton, MR .
TRANSPLANTATION, 2000, 70 (02) :292-297
[10]   Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease [J].
Ong, J ;
Younossi, ZM ;
Reddy, V ;
Price, LL ;
Gramlich, T ;
Mayes, J ;
Boparai, N .
LIVER TRANSPLANTATION, 2001, 7 (09) :797-801